GLP-1RA use was associated with a reduced risk of neurocognitive disorders (e.g., dementia and Alzheimers disease), seizures, thromboembolic disorders, pulmonary hypertension, chronic phlebitis, coagulopathy, and clotting disorders
Bupropion has been reported to improve symptoms of apathy in cases of acquired brain injury, major depression (Corcoran et al
It is reasonable to expect that similar dynamics could apply with retatrutide, meaning that one participant may require a higher dose to achieve the same outcomes as another
Other Contributing Factors Beyond medical conditions and lifestyle, other factors can contribute to cramp risk with semaglutide: Medication Interactions : Some medications interact with semaglutide, increasing cramp risk
Back Richmond, C (30 June 2006) 'Dr Ellis Samols', The Independent